Abstract
The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 287-296 |
Number of pages | 10 |
Journal | Surgical Pathology Clinics |
Volume | 11 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2018 |
Keywords
- Diagnostic criteria
- Directly acting antivirals
- Hepatitis C
- Histology
- Liver biopsy
- Transient elastography
ASJC Scopus subject areas
- Surgery
- Pathology and Forensic Medicine